Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 First-In-Human Study of HBN-1 in Patients Resuscitated Following Out-of-Hospital Cardiac Arrest

NCT04094857 is registered in ClinicalTrials.gov with Hibernaid, Inc as lead sponsor.

NCT NCT04094857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04094857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 First-In-Human Study of HBN-1 in Patients Resuscitated Following Out-of-Hospital Cardiac Arrest
Lead sponsor
Hibernaid, Inc
Phase
Phase 1
Overall status
Unknown status
Start date
October 30, 2019
Completion date
December 31, 2020
Enrollment
18 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest